Sanofi and GlaxoSmithKline Snag Biggest Government Deal Yet for Covid-19 Vaccine

The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.